Colorectal Cancer Liver Metastases Clinical Trials

16 clinical trials for Colorectal Cancer Liver Metastases across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases — RECRUITING
• AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC) — RECRUITING · PHASE2
• AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study) — RECRUITING
• The DRAGON 2 Trial — RECRUITING · NA
• Utilizing Discarded Livers from Donors with a History of Cancer for Patients Lacking Access to Standard Allocation: A Compassionate Use Exploratory Study — RECRUITING
• Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases — RECRUITING · PHASE3
• Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases — NOT_YET_RECRUITING · PHASE2
• Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype — TERMINATED · PHASE1
• Aspirin in Colorectal Cancer Liver Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II) — NOT_YET_RECRUITING
• Multi-mode Ablation and Molecular Imaging Multi-omics Study for Digestive-Origin Malignant Liver Tumors — ACTIVE_NOT_RECRUITING · NA
• Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis Patient — OTHER · NA
• DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Combined PVE/HVE — OTHER · NA
• Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases — OTHER · PHASE2
• Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM — OTHER · PHASE2
• PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES — COMPLETED · PHASE2

Refine this search